ConductScience.org, home

Paper129332

[Differentiation of the mechanisms inducing segmentation and asymetry of chromatids after treatment with 5-bromodeoxyuridine].

Dutrillaux B and 2 others. Exp Cell Res, 1976. Cited by 17 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. [Differentiation of the mechanisms inducing segmentation and asymetry of chromatids after treatment with 5-bromodeoxyuridine]. Papers, record 129332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/129332

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Differentiation of the mechanisms inducing segmentation and asymetry of chromatids after treatment with 5-bromodeoxyuridine].
PubMed
Journal
Exp Cell Res
PubMed
Year
1976
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2019-07-07
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dutrillaux BB
2Aurias AA
3Fosse AMA M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BromodeoxyuridineMajor topic
Chromosome AberrationsMajor topic
ChromosomesMajor topic
MitosisMajor topic
Chromatin
Floxuridine
Humans
Lymphocytes
Protein Conformation
Thymidine
Uracil Nucleotides
Uridine

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
3817806Different reactivity of Z-DNA antibodies with human chromosomes modified by actinomycin D and 5-bromodeoxyuridine.Hum Genet1987https://conductscience.org/library/papers/3817806PubMed
3169735Cell cycle studies in chorionic villi.Hum Genet1988https://conductscience.org/library/papers/3169735PubMed
75162Silver-staining specificity in metaphases after incorporation of 5-bromodeoxyuridine (BUDR).Hum Genet1978https://conductscience.org/library/papers/75162PubMed
66179The relationship between DNA replication and chromosome structure.Hum Genet1977https://conductscience.org/library/papers/66179PubMed
63442Segmentation of human chromosomes induced by 5-ACR (5-azacytidine).Hum Genet1976https://conductscience.org/library/papers/63442PubMed
56297[Various banding simultaneously obtained on the same slides, after treatment by BrdU (author's transl)].Humangenetik1975https://conductscience.org/library/papers/56297PubMed
52433[Discontinued treatment with BudR and staining with acridine orange: observation of R- or Q- or intermediary banding (author's transl)].Chromosoma1975https://conductscience.org/library/papers/52433PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/129332

GET https://conductscience.org/api/papers/v1/129332/authors